PRCM
ADVM

Pine River Capital Management’s Adverum Biotechnologies ADVM Stock Holding History

Pine River Capital Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,589
Closed -$421K – 628
2015
Q2 		$421K Hold
2,589
– – ﹤0.01% 607
2015
Q1 		$1.05M Hold
2,589
– – 0.01% 413
2014
Q4 		$1.4M Sell
2,589
-2,590
-50% -$998K 0.02% 468
2014
Q3 		$1.77M Buy
+5,179
New +$1.54M 0.02% 490

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Pine River Capital Management's ADVM Position: Q3 2015 in Review

Pine River Capital Management sold out of Adverum Biotechnologies (ADVM) in Q3 2015, closing a stake of 2,589 shares — an estimated $421K sold.

Pine River Capital Management first reported a position in ADVM in Q3 2014 and held it in 4 quarters. The position peaked at $1.77M in Q3 2014. 92 funds tracked by Wall St. Rank hold ADVM as of Q3 2015.

  • Pine River Capital Management reported no remaining Adverum Biotechnologies position as of Q3 2015 after selling out during the quarter.
  • Pine River Capital Management sold 2,589 Adverum Biotechnologies shares in Q3 2015, an estimated $421K.
  • Pine River Capital Management first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 4 quarters.
  • Pine River Capital Management's Adverum Biotechnologies position peaked at $1.77M in Q3 2014.
  • 92 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2015.

Based on Pine River Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.